processes

A collection of 499 selected human endogenous metabolites for high throughput and high content screening.

A unique collection of 263 kinase inhibitors regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;

A unique collection of 237 Wnt Hedgehog Notch signaling targeted compounds for high throughput and high content screening;

A unique collection of 485 PPI-related compounds for drug screening;

Well-chosen 1246 compounds with unique structures targeting nervous system;

Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;

A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 252 JAK STAT signaling targeted compounds for high throughput and high content screening;

A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;

A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；

A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening;

A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.

A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS;

A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening;

A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;

A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 420 natural flavor small molecules.